Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Sanofi to cut 1,000-2,000 jobs in France
Reuters
Thu, 07/5/12 - 12:52 pm
France
layoffs
Sanofi
Eli Lilly: A Long-Term Growth Stock
Seeking Alpha
Mon, 07/2/12 - 10:42 am
Eli Lilly
diabetes
Bristol-Myers Squibb
Incyte
Merck
Sanofi
Novo Nordisk
MenHibrix: GlaxoSmithKline Pharmaceuticals' Shot In The Arm
Seeking Alpha
Wed, 06/27/12 - 12:44 pm
MenHibrix
GSK
Merck
Novartis
Pfizer
Sanofi
Novartis, four others weigh Amylin final bids: sources
Reuters
Tue, 06/26/12 - 01:26 pm
Novartis
Amylin
M&A
Bristol-Myers Squibb
AstraZeneca
Merck
Sanofi
Who Got The Most Buzz At The Noisy BIO Show…
Pharmalot
Sun, 06/24/12 - 11:43 am
Sanofi
AstraZeneca
Pfizer
GSK
Eli Lilly
Johnson & Johnson: Charges Could Damage Stock
Seeking Alpha
Fri, 06/22/12 - 10:27 am
JNJ
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
AstraZeneca Will Soar On 2 New Drugs In 2013
Seeking Alpha
Thu, 06/21/12 - 05:54 pm
AstraZeneca
Bristol-Myers Squibb
JNJ
Eli Lilly
AZD4547
Merck
Sanofi
Dapagliflozin
[video] Sanofi CEO's M&A Outlook
CNBC
Wed, 06/20/12 - 11:46 am
Sanofi
M&A
Pharma CEOs
Chris Viehbacher
Merck: Can 5 New Drugs Fill Singulair Gap?
Seeking Alpha
Tue, 06/19/12 - 10:21 am
Merck
Singulair
Pfizer
AstraZeneca
Sanofi
Forest Labs
Bristol-Myers Squibb
suvorexant
Eli Lilly
Bridon
V503
Endocyte
Tredaptive
Novartis: Diversification For Stability
Seeking Alpha
Tue, 06/19/12 - 09:11 am
Novartis
Abbott Laboratories
JNJ
Merck
Pfizer
Sanofi
Genzyme seeks approvals for MS drug
Boston Globe, MA
Wed, 06/13/12 - 12:55 pm
MS
multiple sclerosis
Genzyme
Sanofi
Lemtrada
Who Got The Most Buzz At The Diabetes Show?
Pharmalot
Wed, 06/13/12 - 12:05 pm
ADA
diabetes
JNJ
Eli Lilly
Novo Nordisk
Sanofi
Bristol-Myers Squibb
ADA cancer-risk data clears Sanofi's Lantus
Fierce Pharma
Tue, 06/12/12 - 10:58 am
diabetes
insulin
Lantus
Sanofi
cancer
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
ASCO
Arqule
Array Biopharma
Astex
AstraZeneca
Bristol-Myers Squibb
GSK
Curis
Exelixis
Pfizer
Immunogen
Seattle Genetics
Sanofi
Synta
Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA
Fierce Pharma
Mon, 06/11/12 - 01:17 pm
Sanofi
Novo Nordisk
ADA
diabetes
Amylin
degludec
Lantus
Victoza
Zealand Pharma Announces GetGoal Duo 1 and GetGoal-L Phase III Data on Lixisenatide (Lyxumia(R))1 to be Presented at ADA
Yahoo/Global NewsWire
Sun, 06/10/12 - 11:14 am
lixisenatide
Zealand Pharma
Sanofi
type 2 diabetes
diabetes
Lyxumia(R) (lixisenatide) in Combination With Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose
Yahoo/MarketWire
Sun, 06/10/12 - 11:12 am
lixisenatide
type 2 diabetes
diabetes
Sanofi
Lantus(R) Initiation After Metformin Achieved Superior Glycemic Control Versus Sitagliptin in Type 2 Diabetes
Yahoo
Sat, 06/9/12 - 12:41 pm
Lantus
type 2 diabetes
sitagliptin
Sanofi
Amylin Said To Draw Bids Of $25 To $29 A Share In First Round
Bloomberg
Tue, 06/5/12 - 09:39 am
Amylin
M&A
Sanofi
AstraZeneca
Merck
Bristol-Myers Squibb
Positive Data for Sanofi's Aubagio
Yahoo/Zacks.com
Mon, 06/4/12 - 10:56 am
Sanofi
Aubagio
Genzyme
multiple sclerosis
Pages
« first
‹ previous
…
103
104
105
106
107
108
109
110
111
…
next ›
last »